Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04246996 · ClinicalTrials.gov registry record · Phase 2
Gentamicin Intravesical Efficacy for Infection of Urinary Tract
A Phase 2 study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 2
- Development phase
- 370
- Enrollment target
NCT04246996: Completed Phase 2 study, sponsored by Kaiser Permanente.
NCT04246996 is a Phase 2 study that has completed, run by Kaiser Permanente. The registered enrollment target is 370 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (178% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04246996, a Phase 2 study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 370 participants
- Enrollment target
Study Summary
Urinary tract infection (UTI) is a common problem after surgery for pelvic organ prolapse and stress urinary incontinence. This prospective, randomized, single-masked (subject), two-parallel armed study aims to determine the effect of a single postoperative intravesical instillation of 80 mg of gentamicin sulfate in 50 mL of saline versus usual care on the proportion of women treated for UTI within 6 weeks following surgery for pelvic organ prolapse (POP) or stress urinary incontinence (SUI).
Primary Outcome
Number of participants in each arm treated with antibiotics for urinary tract infection symptoms
Interventions
- DRUG gentamicin sulfate
- OTHER Catheter clamping only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2020-01-29 |
| Est. Completion | 2021-12-05 |
| Phase | Phase 2 |
What the finished NCT04246996 record still lists
NCT04246996 is an interventional study that assigns participants to a tested intervention. The registered 370 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (178% higher).
The record links to 0 conditions, and to 2 interventions - of which gentamicin sulfate is the first listed.
NCT04246996 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04246996 about?
NCT04246996 is a clinical study titled "Gentamicin Intravesical Efficacy for Infection of Urinary Tract". Urinary tract infection (UTI) is a common problem after surgery for pelvic organ prolapse and stress urinary incontinence. This prospective, randomized, single-masked (subject), two-parallel armed study aims to determine the effect of a single postoperative intravesical instillation of 80 mg of gent...
What is the current status of trial NCT04246996?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 370 participants. The study started on 2020-01-29. Estimated completion is 2021-12-05.
What interventions are being tested in trial NCT04246996?
The interventions under investigation include: gentamicin sulfate (DRUG), Catheter clamping only (OTHER).
Who is sponsoring clinical trial NCT04246996?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04246996's enrollment target sits among peer trials
370 120th of 2000 higher than 1,880 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02332668 · 370 participants · Phase 1
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- NCT04284436 · 370 participants · NA
Study in Parkinson Disease of Exercise
- NCT05026749 · 370 participants · Phase 3
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
- NCT05125016 · 370 participants · Phase 1
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI